Literature DB >> 11549601

PAX3-FKHR induces morphological change and enhances cellular proliferation and invasion in rhabdomyosarcoma.

J Anderson1, A Ramsay, S Gould, K Pritchard-Jones.   

Abstract

Alveolar rhabdomyosarcoma (ARMS) is consistently associated with the characteristic translocations t(2;13)(q35;q14) and t(1;13)(p36;q14), which encode for the PAX3-FKHR and PAX7-FKHR fusion oncoproteins respectively. We have investigated the relationship between PAX3-FKHR expression and ARMS histogenesis in primary tumors and cell culture systems. In a blinded histological review of discrepant primary tumors in which there was PAX3-FKHR expression but embryonal histology, we found small areas of alveolar histology in 6 of 11 cases. This suggests that histology alone may under-represent the association between PAX3-FKHR and ARMS, and we investigated this link by examining the effect of ectopic PAX3-FKHR expression on RMS cells. Two cell lines, RD and HX170C, were stably transfected with a PAX3-FKHR expression construct. In cloned transfectants derived from both lines, PAX3-FKHR expression resulted in increased proliferative rate in vitro and promoted cell growth in the absence of added growth factors. Tumors that formed as xenografts in immunodeficient mice were faster growing, more locally invasive, and had a denser, more pleomorphic architecture than untransfected or empty vector transfected tumors. The characteristic clefts and alveolar spaces of ARMS, however, were not seen. In contrast, tumors grown as xenografts from individual clones derived from ARMS cell lines showed all of the classical morphological features of ARMS suggesting divergence in vivo from precursor cells propagated in culture.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11549601      PMCID: PMC1850440          DOI: 10.1016/S0002-9440(10)61784-1

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  28 in total

1.  PAX3 and PAX7 exhibit conserved cis-acting transcription repression domains and utilize a common gain of function mechanism in alveolar rhabdomyosarcoma.

Authors:  J L Bennicelli; S Advani; B W Schäfer; F G Barr
Journal:  Oncogene       Date:  1999-07-29       Impact factor: 9.867

2.  Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67.

Authors:  J Gerdes; L Li; C Schlueter; M Duchrow; C Wohlenberg; C Gerlach; I Stahmer; S Kloth; E Brandt; H D Flad
Journal:  Am J Pathol       Date:  1991-04       Impact factor: 4.307

3.  Coexpression of intermediate filament polypeptides in human fetal and adult tissues.

Authors:  G N Van Muijen; D J Ruiter; S O Warnaar
Journal:  Lab Invest       Date:  1987-10       Impact factor: 5.662

4.  cDNA microarrays detect activation of a myogenic transcription program by the PAX3-FKHR fusion oncogene.

Authors:  J Khan; M L Bittner; L H Saal; U Teichmann; D O Azorsa; G C Gooden; W J Pavan; J M Trent; P S Meltzer
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

5.  Fusion of PAX7 to FKHR by the variant t(1;13)(p36;q14) translocation in alveolar rhabdomyosarcoma.

Authors:  R J Davis; C M D'Cruz; M A Lovell; J A Biegel; F G Barr
Journal:  Cancer Res       Date:  1994-06-01       Impact factor: 12.701

6.  Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma.

Authors:  N Galili; R J Davis; W J Fredericks; S Mukhopadhyay; F J Rauscher; B S Emanuel; G Rovera; F G Barr
Journal:  Nat Genet       Date:  1993-11       Impact factor: 38.330

7.  Fusion of PAX3 to a member of the forkhead family of transcription factors in human alveolar rhabdomyosarcoma.

Authors:  D N Shapiro; J E Sublett; B Li; J R Downing; C W Naeve
Journal:  Cancer Res       Date:  1993-11-01       Impact factor: 12.701

8.  Activation of an imprinted allele of the insulin-like growth factor II gene implicated in rhabdomyosarcoma.

Authors:  S Zhan; D N Shapiro; L J Helman
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

9.  Variant translocations of chromosome 13 in alveolar rhabdomyosarcoma.

Authors:  E C Douglass; S T Rowe; M Valentine; D M Parham; R Berkow; W P Bowman; H M Maurer
Journal:  Genes Chromosomes Cancer       Date:  1991-11       Impact factor: 5.006

10.  Rhabdomyosarcoma. A new classification scheme related to prognosis.

Authors:  M Tsokos; B L Webber; D M Parham; R A Wesley; A Miser; J S Miser; E Etcubanas; T Kinsella; J Grayson; E Glatstein
Journal:  Arch Pathol Lab Med       Date:  1992-08       Impact factor: 5.534

View more
  27 in total

1.  Macrophage migration inhibitory factor is secreted by rhabdomyosarcoma cells, modulates tumor metastasis by binding to CXCR4 and CXCR7 receptors and inhibits recruitment of cancer-associated fibroblasts.

Authors:  Maciej Tarnowski; Katarzyna Grymula; Rui Liu; Joanna Tarnowska; Justyna Drukala; Janina Ratajczak; Robert A Mitchell; Mariusz Z Ratajczak; Magda Kucia
Journal:  Mol Cancer Res       Date:  2010-09-22       Impact factor: 5.852

2.  Comparative analysis of paired- and homeodomain-specific roles in PAX3-FKHR oncogenesis.

Authors:  Youbin Zhang; Joel Schwartz; Chiayeng Wang
Journal:  Int J Clin Exp Pathol       Date:  2008-12-01

3.  High IGFBP2 expression correlates with tumor severity in pediatric rhabdomyosarcoma.

Authors:  Lucia Tombolan; Francesca Orso; Vincenza Guzzardo; Silvia Casara; Angelica Zin; Massimo Bonora; Chiara Romualdi; Carlotta Giorgi; Gianni Bisogno; Rita Alaggio; Paolo Pinton; Cristiano De Pittà; Daniela Taverna; Angelo Rosolen; Gerolamo Lanfranchi
Journal:  Am J Pathol       Date:  2011-09-13       Impact factor: 4.307

4.  Identification of a new class of PAX3-FKHR target promoters: a role of the Pax3 paired box DNA binding domain.

Authors:  L Zhang; C Wang
Journal:  Oncogene       Date:  2006-09-11       Impact factor: 9.867

5.  Pax3-FKHR knock-in mice show developmental aberrations but do not develop tumors.

Authors:  Irina Lagutina; Simon J Conway; Jack Sublett; Gerard C Grosveld
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

Review 6.  PAX3-FOXO1 fusion gene in rhabdomyosarcoma.

Authors:  Corinne M Linardic
Journal:  Cancer Lett       Date:  2008-05-23       Impact factor: 8.679

7.  Molecular classification of rhabdomyosarcoma--genotypic and phenotypic determinants of diagnosis: a report from the Children's Oncology Group.

Authors:  Elai Davicioni; Michael J Anderson; Friedrich Graf Finckenstein; James C Lynch; Stephen J Qualman; Hiroyuki Shimada; Deborah E Schofield; Jonathan D Buckley; William H Meyer; Poul H B Sorensen; Timothy J Triche
Journal:  Am J Pathol       Date:  2009-01-15       Impact factor: 4.307

Review 8.  Gene translocations in musculoskeletal neoplasms.

Authors:  Balaji Krishnan; Gaurav Khanna; Denis Clohisy
Journal:  Clin Orthop Relat Res       Date:  2008-06-20       Impact factor: 4.176

Review 9.  Myogenin and MyoD1 expression in paediatric rhabdomyosarcomas.

Authors:  N J Sebire; M Malone
Journal:  J Clin Pathol       Date:  2003-06       Impact factor: 3.411

Review 10.  Soft tissue sarcomas with non-EWS translocations: molecular genetic features and pathologic and clinical correlations.

Authors:  Cyril Fisher
Journal:  Virchows Arch       Date:  2009-04-28       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.